Hadassah

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Monday, May 7 2018

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

PLX-R18’s initial critical preclinical animal studies that set the basis for this treatment were performed by Prof. Gorodetsky at Hadassah. Further preclinical trials conducted by the U.S. National Institutes of Health, Prof. Gorodetsky at Hadassah, researchers at the Charité University Hospital in Berlin, and other prominent research institutions have shown that PLX-R18 cells secrete a range of specific proteins that salvage and trigger the regeneration of bone marrow hematopoietic (blood-producing) cells. In this way, they efficiently support the indirect recovery and regeneration of the blood system.

Read more about the development and milestones of PLX-R18 at:
http://www.hadassah.org/news-stories/placental-stem-cell-therapy-fda.html

Dr. Gorodetsky’s family has been intertwined with Hadassah for 70 years.  Listen as he traces this connection back to 1948.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jan 16 2019

Hadassah Hospital Ein Kerem Receives Award for Premature Babies

Our Hadassah stars! The staff at Hadassah Hospital Ein Kerem was awarded the “Outstanding Pagination” Award in the Ministry of Health’s 2018 Star Program.

READ MORE ›
alt_text

Monday, Jan 14 2019

When Arms Don’t Match: Hadassah Surgeon Repairs Complex Long-term Injury

Oshry was two years old when his father broke his arm the first time. The second time, social services got involved.

READ MORE ›
alt_text

Wednesday, Jan 9 2019

Creative “Magic Tricks” Reduce Need to Sedate Kids for Radiation Treatment

Until recently, kids in Israel with cancer were almost always sedated for radiation treatment. At the Hadassah Medical Organization, however, that is changing.

READ MORE ›
alt_text

Monday, Jan 7 2019

From Surviving a Terror Attack to the Birth of a New Baby

Three and a half years ago, Inbar and Ori Azrak were returning from a romantic weekend in Jerusalem when a terrorist threw a Molotov cocktail into their car.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More